Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Shaman Pharmaceuticals has been moving on big, relative, -- Ignore unavailable to you. Want to Upgrade?

To: Daniel Shaffer who wrote (344)	2/1/1999 12:18:00 PM
From: bargainman	Read Replies (2) \| Respond to of 838

According to today's release, Shaman's pharmaceuticals efforts are going to be suspended or "outlicensed," whatever, while the company shifts its focus to the Botanicals side. It's the only way to salvage something for the stockholders. I just hope they can get some product to market before too long. I still feel that we weren't given the whole story on the Provir fiasco. I can't believe that the FDA's caution came as such a big shock to them. They had to have some indications earlier than that.